โœ” Medically Reviewed ๐Ÿ“ Gurgaon โฑ 24 min read Updated 20 Nov 2026

Primary Sclerosing Cholangitis in Gurgaon: Understanding Bile Duct Inflammation, Liver Changes and Long-Term Monitoring

Serving patients across Gurgaon through our regional care network.

Quick summary: Primary sclerosing cholangitis (PSC) is a long-term liver disease in which the bile ducts inside and outside the liver slowly become inflamed, scarred and narrowed. Over years this blocks bile flow, injures liver cells and can progress to cirrhosis, bile duct infection or bile duct cancer. This guide explains PSC symptoms, tests, complications and how patients in Gurgaon are monitored safely at home between hospital visits.

What is primary sclerosing cholangitis?

Answer: Primary sclerosing cholangitis (PSC) is a chronic, progressive liver disease in which the bile ducts become inflamed and scarred. The scarring narrows the ducts, slows bile flow, damages liver cells and can eventually lead to cirrhosis, liver failure or bile duct cancer. There is no cure, so careful monitoring is essential.

Primary sclerosing cholangitis is a long-term condition of the liver and bile ducts. The word cholangitis means inflammation of the bile ducts, and sclerosing refers to the hardening or scarring that develops over time. In PSC, both the small bile ducts inside the liver and the larger ducts outside the liver can be affected.

For a person living in Gurgaon, PSC often comes to attention after a routine health check shows abnormal liver function tests, especially a raised alkaline phosphatase (ALP). Many patients have no symptoms at the time of diagnosis, which is why PSC is sometimes called a “silent” liver disease in its early phase. The disease then unfolds slowly, often over ten to twenty years.

Because PSC cannot be reversed with medication, the focus of modern care is on early detection of complications. Patients usually need a hepatologist (liver specialist) to lead the medical plan, with home-based nursing support to watch for warning signs between clinic visits. This is where AtHomeCare fits in for families in Gurgaon: we help carry out the monitoring, the medication schedule and the lifestyle steps that the hepatology team has recommended, in a calm and structured way.

Important

PSC is not the same as primary biliary cholangitis (PBC), even though the names sound similar. PBC mostly affects middle-aged women and targets the small bile ducts with a different antibody pattern. Treatment and monitoring also differ. Always confirm the exact diagnosis with your hepatologist.

How bile ducts work and what goes wrong in PSC

Answer: Bile ducts are thin tubes that carry bile from the liver to the gallbladder and small intestine, where bile digests fats. In PSC, inflammation scars and narrows these tubes, so bile builds up inside the liver. This backup injures liver cells, causing the slow damage that defines the disease.

The liver makes bile continuously. Bile has two main jobs: it helps the body absorb fats and fat-soluble vitamins (A, D, E and K), and it carries waste products out of the liver. Bile flows through a branching network of tiny ducts inside the liver, joins larger ducts, and finally reaches the small intestine. Some bile is also stored temporarily in the gallbladder.

In PSC, the immune system appears to attack the lining of these bile ducts. The duct walls become inflamed, then thickened with scar tissue. As scarring grows, the ducts narrow (a stricture) and bile can no longer flow freely. Bile then backs up into the liver, a state called cholestasis. The trapped bile salts are toxic to liver cells, and the slow, steady injury eventually leads to fibrosis and cirrhosis.

This cholestatic pattern is what shows up on blood tests as a raised alkaline phosphatase and gamma-glutamyl transferase (GGT). Imaging tests like MRCP can show the characteristic “beaded” appearance of the ducts, caused by alternating narrowed and slightly widened segments. Understanding this mechanics helps families see why monitoring focuses so heavily on bile flow, duct infections and duct strictures over many years.

How common is PSC and who gets it

Answer: PSC is uncommon, affecting roughly 4 to 15 people per 100,000 worldwide. It is more frequent in men, usually diagnosed between ages 30 and 50, and is strongly linked with inflammatory bowel disease. In India it is considered rare, but awareness and diagnosis are improving.

PSC is a rare disease. Global estimates suggest a prevalence of about 4 to 15 cases per 100,000 people, with higher numbers reported in Northern Europe and North America. Indian data is still limited, but hepatologists in tertiary centres in Delhi NCR, including Gurgaon, do see PSC regularly, and recognition is improving as MRI scanning and liver function testing become routine.

Several patterns are well established:

  • Sex: PSC affects men about twice as often as women.
  • Age: The average age at diagnosis is between 30 and 50 years, although it can appear in children and in older adults.
  • IBD link: Around 60 to 80 percent of people with PSC also have ulcerative colitis or, less often, Crohn’s disease. The bowel disease may be diagnosed before, at the same time as, or years after the PSC.
  • Smoking paradox: Interestingly, smoking appears to lower the risk of PSC and ulcerative colitis, although the reasons are not fully understood and smoking is never recommended for any other reason.

For Gurgaon families, the practical takeaway is that anyone with a confirmed diagnosis of ulcerative colitis or Crohn’s disease should have liver function tests done at least once a year, even if they feel well. This is the single most useful screening step, because PSC often begins silently in people who already carry an IBD diagnosis.

Causes and risk factors

Answer: The exact cause of PSC is unknown, but it is thought to result from an abnormal immune response in people with a genetic predisposition, often triggered by gut bacteria leaking into the bile ducts. Risk factors include male sex, age 30 to 50, inflammatory bowel disease and a family history of PSC.

Doctors and researchers describe PSC as an immune-mediated disease rather than a classic autoimmune disease, because unlike autoimmune hepatitis or PBC, PSC does not have a single diagnostic antibody. The current understanding combines three broad factors:

1. Genetic predisposition

PSC is not directly inherited in a simple pattern, but certain genes that control the immune system (especially the HLA genes) are seen more often in people with PSC. Having a first-degree relative with PSC slightly raises a person’s risk, although the absolute risk remains low.

2. Immune system dysregulation

The immune system appears to mistakenly attack the cells lining the bile ducts. This causes ongoing inflammation and, eventually, scarring. Several immune markers are often raised, but none is specific enough to confirm PSC on its own.

3. Gut-liver axis and bacterial triggers

Because PSC is so closely tied to inflammatory bowel disease, researchers believe that in some people, bacteria or bacterial products from an inflamed gut may travel through the portal vein to the liver and trigger bile duct inflammation. This “gut-to-liver” leak is one of the leading explanations for the IBD-PSC link.

Known risk and association factors for PSC
FactorStrength of linkPractical implication
Ulcerative colitisVery strongAnnual liver function tests in all IBD patients
Crohn’s disease (colonic)ModerateInclude LFTs in routine IBD follow-up
Male sexModerateHigher clinical suspicion in young men with fatigue or itching
Family history of PSCWeak to moderateDiscuss screening with a hepatologist
Smoking (current or former)ProtectiveNot a reason to smoke; risk reduction only
Prior biliary infection or surgeryWeakDistinguish from secondary sclerosing cholangitis
Tip for families

Secondary sclerosing cholangitis can mimic PSC but has a clear cause such as past biliary surgery, stones, infection or a narrowed bile duct from injury. Your hepatologist will rule these out before confirming PSC, because treatment differs.

Early symptoms of PSC

Answer: Early PSC often causes no symptoms and is detected through abnormal liver function tests. When symptoms do appear, they usually include fatigue, itching (pruritus), upper-right abdominal discomfort and, less commonly, episodes of fever with jaundice that suggest a bile duct infection.

Many people with PSC feel completely well at the time of diagnosis. The condition is frequently picked up when routine blood tests for another reason (such as an annual check-up or IBD monitoring) show a raised alkaline phosphatase. This asymptomatic phase can last for years, which makes screening so important.

When early symptoms do develop, they tend to be vague and non-specific:

  • Fatigue: A persistent tiredness that does not improve with rest. Fatigue is the most common symptom in PSC and can be disabling, but it is easy to dismiss as work stress or ageing.
  • Pruritus (itching): Often worse on the arms, legs and back, and more noticeable at night. The itch results from bile salts deposited in the skin and can severely affect sleep and quality of life.
  • Right upper abdominal discomfort: A dull ache or fullness under the ribs on the right side. It is usually mild and not severe.
  • Subtle jaundice: A yellowish tinge in the eyes, noticed first by family members rather than the patient.
  • Episodes of fever and chills: These suggest acute bacterial cholangitis, a true emergency that needs urgent treatment.
Warning

Itching in PSC does not always mean the liver is failing. Some patients with mild disease itch severely, while others with advanced scarring may not itch at all. Never assume that the itch tells you the stage of the disease.

Progressive and advanced symptoms

Answer: As PSC progresses to cirrhosis, symptoms include persistent jaundice, dark urine, pale stools, easy bruising, fluid in the abdomen (ascites), leg swelling, confusion (hepatic encephalopathy) and weight loss. These reflect failing liver function and require prompt specialist review.

When scarring advances and the liver can no longer perform its normal work, the symptoms shift from “bile-flow problems” to “liver-failure problems.” This stage is generally reached after many years, although in some patients it can develop more quickly. The following symptoms usually indicate that PSC has progressed to cirrhosis:

  • Jaundice: Yellowing of the skin and the whites of the eyes, often with dark, tea-coloured urine and pale, clay-coloured stools.
  • Ascites and oedema: Swelling of the abdomen due to fluid, and swelling of the ankles and legs. This happens because the scarred liver cannot make enough albumin and because of raised pressure in the portal vein.
  • Bruising and bleeding: The liver stops making enough clotting factors, so bruises appear easily and gums may bleed.
  • Hepatic encephalopathy: Toxins that the liver normally clears begin to affect the brain. Early signs include forgetfulness, mild confusion, sleep reversal (awake at night, sleepy by day) and poor concentration. Severe forms cause drowsiness and, in extreme cases, coma.
  • Weight loss and muscle wasting: Common in advanced liver disease, partly from poor appetite and partly from altered metabolism.
  • Recurrent bacterial cholangitis: Repeated episodes of fever, rigors (shaking chills) and jaundice often mean a major stricture or a stone has blocked a duct.
Emergency note

If a person with PSC develops high fever with shaking chills, worsening jaundice, severe abdominal pain or marked drowsiness, treat it as a medical emergency. These suggest acute cholangitis or decompensated cirrhosis. Go to a hospital emergency department immediately and inform the team of the PSC diagnosis.

PSC and inflammatory bowel disease

Answer: PSC is strongly associated with inflammatory bowel disease, especially ulcerative colitis. Around 60 to 80 percent of people with PSC also have IBD. The two conditions share immune and gut-liver links, and patients with both need combined hepatology and gastroenterology care plus yearly colon cancer screening.

The link between PSC and inflammatory bowel disease (IBD) is one of the strongest disease associations in medicine. Roughly two out of every three patients with PSC will also be diagnosed with ulcerative colitis or Crohn’s disease, and a smaller but significant share of patients with IBD will go on to develop PSC. The relationship runs in both directions, which is why a hepatology review is recommended for any IBD patient with persistently abnormal liver tests.

Several points matter for day-to-day care:

  • IBD in PSC is often mild: The bowel symptoms can be quiet even when the liver disease is active, so do not assume the bowel is fine just because there is no diarrhoea or bleeding.
  • Higher colon cancer risk: People with both PSC and IBD have a much higher lifetime risk of colorectal cancer than people with IBD alone. International guidelines recommend a colonoscopy at diagnosis of PSC and then every one to two years.
  • Colectomy does not cure PSC: Removing the colon does not stop the liver disease from progressing, although it may reduce some cancer risk.
  • Medication interactions: Some IBD drugs can affect the liver, and some liver drugs can affect the gut. A combined plan between the hepatologist and gastroenterologist avoids conflicting treatments.

For families in Gurgaon, AtHomeCare’s nursing teams often help coordinate these two specialist pathways. A nurse visiting the home can collect the medication list, observe both liver and bowel symptoms, and prepare a clear summary so that the hepatologist and gastroenterologist are reading from the same page at the next clinic visit.

How PSC is diagnosed

Answer: PSC is diagnosed by combining abnormal liver function tests (especially raised ALP and GGT), characteristic bile duct changes on MRCP imaging, and exclusion of other causes. A liver biopsy may be needed for small-duct PSC or when overlap with autoimmune hepatitis is suspected.

No single test confirms PSC. Instead, the diagnosis is built from a combination of evidence. A hepatologist typically works through five steps:

  1. Blood tests to show a cholestatic pattern and to rule out other liver diseases.
  2. Magnetic resonance cholangiopancreatography (MRCP) to visualise the bile ducts without radiation or scopes.
  3. Exclusion of secondary causes such as stones, surgery, infection or tumour.
  4. Liver biopsy when imaging is normal but suspicion remains, or to look for overlap syndromes.
  5. Endoscopic retrograde cholangiopancreatography (ERCP) in selected cases, both to confirm the diagnosis and to treat strictures.

A typical diagnostic report for someone with PSC will show a cholestatic liver panel, a “beaded” or irregular bile duct tree on MRCP, normal or only mildly raised immunoglobulins, and absence of antimitochondrial antibodies (which would point to PBC instead). In about 10 to 15 percent of patients, only the small ducts inside the liver are affected; this “small-duct PSC” has a better prognosis and is usually confirmed on biopsy.

Tip

Carry copies of all imaging (MRCP films or a CD), biopsy slides and the most recent blood reports to every clinic visit. A single organised file saves time and reduces repeated tests, which is especially useful when care is split between a hospital and a home nursing team.

Liver function tests explained

Answer: Liver function tests measure enzymes and proteins in the blood that reflect bile flow, liver cell injury and liver function. In PSC, alkaline phosphatase (ALP) and GGT are usually most raised, while ALT and AST are mildly high. Bilirubin rises when ducts are blocked or in advanced disease.

Liver function tests (LFTs) are a group of blood tests that together tell doctors how the liver and bile ducts are behaving. In PSC, certain patterns are typical and others raise the suspicion of complications. The table below explains each test in plain language.

Liver function tests and what they show in PSC
TestWhat it measuresTypical pattern in PSC
Alkaline phosphatase (ALP)Enzyme from bile duct liningOften markedly raised; key marker
Gamma-glutamyl transferase (GGT)Enzyme confirming ALP is from liverRaised alongside ALP
ALT and ASTEnzymes from liver cellsMildly to moderately raised
Bilirubin (total and direct)Bile pigment in bloodNormal early; rises with strictures or advanced disease
AlbuminProtein made by the liverFalls in advanced disease
PT/INRClotting functionProlonged in advanced disease
Platelet countIndirect sign of portal hypertensionLow in cirrhosis with spleen enlargement

Two practical points are often missed. First, the level of ALP does not reliably predict how severe the disease is or how fast it is progressing. A patient with a very high ALP can be stable for years, while another with a modest ALP can develop complications quickly. Second, a sudden jump in bilirubin, especially with fever, usually means a new stricture, a stone or a duct infection and should prompt urgent review rather than waiting for the next routine appointment.

Imaging: MRCP, ERCP and ultrasound

Answer: MRCP is the preferred first imaging test for PSC because it shows the bile ducts clearly without radiation or scopes. Ultrasound is used for routine screening for gallbladder and bile duct cancer. ERCP is reserved for diagnosing and treating major duct strictures, stones or stent placement.

Imaging plays a central role in both diagnosing PSC and monitoring it over the years. Each test has a clear purpose:

Ultrasound of the abdomen

This is the simplest and most widely available test. In PSC it is used to look for gallbladder stones, bile duct widening, liver nodules, fluid in the abdomen and signs of portal hypertension such as an enlarged spleen. From the time of PSC diagnosis, an ultrasound of the gallbladder and bile ducts is usually recommended every six to twelve months because of the higher risk of bile duct and gallbladder cancer.

Magnetic resonance cholangiopancreatography (MRCP)

MRCP is a special type of MRI that produces very detailed pictures of the bile ducts and pancreatic ducts without using an endoscope or radiation. It is the gold standard for diagnosing PSC. The classic appearance is a “beaded” or “pruned tree” pattern caused by multiple short strictures alternating with slightly dilated segments. MRCP is painless, takes about 30 to 45 minutes and is widely available at imaging centres across Gurgaon.

Endoscopic retrograde cholangiopancreatography (ERCP)

ERCP is more invasive. A flexible scope is passed through the mouth into the small intestine, where a small opening (the ampulla) is cannulated to inject dye into the bile duct under X-ray guidance. ERCP is no longer used only to diagnose PSC, because MRCP does that well. ERCP is now mainly used to treat problems: to dilate a tight stricture, place a stent, remove stones or take brushings if cancer is suspected.

Computed tomography (CT) and MRI of the liver

These are used when a mass is seen on ultrasound, when there is suspicion of cholangiocarcinoma, or to plan for liver transplant. They give detailed information about liver structure, blood vessels and tumour spread.

Liver biopsy in PSC

Answer: A liver biopsy removes a tiny piece of liver with a needle for microscopic examination. In PSC it is used when MRCP looks normal but suspicion remains, for small-duct PSC, or to check for overlap with autoimmune hepatitis. It is a safe day-care procedure when done by trained hands.

With modern MRCP imaging, liver biopsy is needed less often than it once was, but it still has three important roles in PSC:

  1. Confirming small-duct PSC: When MRCP looks normal but LFTs are cholestatic, biopsy can show the characteristic “onion-skin” fibrosis around small bile ducts that defines small-duct PSC. This subtype has a better prognosis than classic large-duct PSC.
  2. Looking for overlap syndromes: Some patients have features of both PSC and autoimmune hepatitis. Identifying this overlap matters because autoimmune hepatitis component may respond to steroids, while PSC itself does not.
  3. Staging fibrosis: Biopsy can show how much scarring is present, although non-invasive methods like elastography are now preferred for routine monitoring.

The procedure is usually done under local anaesthetic, with ultrasound guidance, in a day-care setting. Patients go home the same day but need to rest for 24 hours and watch for pain at the biopsy site or shoulder-tip pain, which can indicate minor bleeding. AtHomeCare nurses can help families prepare for the biopsy (fasting, stopping certain blood thinners on the doctor’s advice) and monitor recovery at home afterwards.

Tip

Ask your hepatologist whether a non-invasive liver stiffness test (FibroScan or MR elastography) can replace or reduce the number of biopsies you need. These tests measure how stiff the liver is and are increasingly used to track fibrosis without needles.

Differential diagnosis: conditions that mimic PSC

Answer: Several conditions can look like PSC, including primary biliary cholangitis, autoimmune hepatitis overlap, secondary sclerosing cholangitis from stones or surgery, IgG4-related disease and cholangiocarcinoma. Careful blood tests, imaging and sometimes biopsy are needed to tell them apart, because treatment differs.

Making the correct diagnosis matters because treatments and outlook differ widely. The main conditions that can be confused with PSC include:

PSC and its main differential diagnoses
ConditionKey difference from PSC
Primary biliary cholangitis (PBC)Mostly middle-aged women; antimitochondrial antibody positive; small ducts mainly affected
Autoimmune hepatitisHigher ALT/AST, raised IgG, positive ANA and smooth muscle antibody; responds to steroids
Secondary sclerosing cholangitisHas a clear cause: past biliary surgery, stones, infection or ischaemia
IgG4-related sclerosing cholangitisRaised serum IgG4; responds well to steroids; often with pancreatic swelling
CholangiocarcinomaMass lesion or progressive stricture; biopsy or brushings needed; weight loss common
Infectious cholangitis (recurrent)Episodes of fever and jaundice with stones or strictures; treat the obstruction

A careful workup by a hepatologist, with the right combination of blood tests, MRCP and (when needed) biopsy or ERCP with brushings, can usually separate these conditions. Patients should never accept a PSC label based on a single abnormal LFT; the diagnosis depends on a consistent pattern across tests.

Complications of PSC

Answer: PSC complications include recurrent bacterial cholangitis, bile duct strictures, gallbladder and bile stones, fat-soluble vitamin deficiency, osteoporosis, cirrhosis, portal hypertension, liver failure, bile duct cancer (cholangiocarcinoma), gallbladder cancer and colon cancer in patients with IBD. Each complication needs a specific monitoring plan.

The complications of PSC fall into three broad groups, and a good monitoring plan addresses all three.

Bile-flow complications

  • Recurrent bacterial cholangitis from blocked ducts.
  • Stones in the gallbladder and bile ducts.
  • Dominant strictures that need dilation or stenting.

Long-term liver complications

  • Cirrhosis with portal hypertension, ascites and variceal bleeding.
  • Liver failure requiring transplant assessment.
  • Hepatic encephalopathy from toxins reaching the brain.

Cancer risks

  • Cholangiocarcinoma (bile duct cancer) โ€” lifetime risk roughly 10 to 15 percent.
  • Gallbladder cancer โ€” yearly ultrasound is recommended.
  • Colorectal cancer โ€” only in patients who also have IBD; colonoscopy every one to two years.
  • Hepatocellular carcinoma โ€” lower than in viral cirrhosis but still screened for with ultrasound every six months once cirrhosis develops.
Warning

A “dominant stricture” is a significantly narrowed section of the common bile duct that can cause jaundice, cholangitis or rising bilirubin. If you have PSC and your bilirubin rises sharply, your hepatologist will usually arrange an MRCP and possibly an ERCP to check for a dominant stricture and to take brushings to exclude cancer.

Cholangiocarcinoma (bile duct cancer) and PSC

Answer: Cholangiocarcinoma is cancer of the bile ducts and is one of the most serious complications of PSC, with a lifetime risk of about 10 to 15 percent. It is hard to detect early. Warning signs include rapid worsening of jaundice, weight loss, new abdominal pain and a rising CA 19-9, but no single test is fully reliable.

Cholangiocarcinoma is the complication that patients and families worry about most, and rightly so. The risk is real but not overwhelming: roughly one in eight people with PSC will develop bile duct cancer over their lifetime. The challenge is that cholangiocarcinoma can be hard to find early, because the bile ducts in PSC are already abnormal on imaging, which hides small tumours.

Doctors use several tools together to look for cholangiocarcinoma:

  • Regular MRCP and ultrasound: to look for new strictures, masses or rapid changes.
  • Blood tumour marker CA 19-9: a blood test that can rise in cholangiocarcinoma, but it is not specific and can also rise in simple obstruction or inflammation.
  • ERCP with brushings: when a suspicious stricture is found, cells are brushed off during ERCP and sent for examination.
  • Positron emission tomography (PET-CT): sometimes used to detect metabolically active tumours.
Emergency note

If a person with PSC develops rapidly worsening jaundice, unintentional weight loss, new persistent upper abdominal pain that radiates to the back, or drenching night sweats, contact the hepatologist within days rather than waiting for the next routine appointment. These are red flags that require imaging.

No screening programme can guarantee early detection, which is why close, structured follow-up by a hepatologist is the best defence. For Gurgaon families, our role at AtHomeCare is to keep a clear log of symptoms, weight and blood reports so that subtle changes are noticed quickly and shared with the treating team.

Cirrhosis, portal hypertension and liver failure

Answer: Cirrhosis is advanced scarring of the liver that develops in many PSC patients after many years. It raises pressure in the portal vein, leading to ascites, variceal bleeding, spleen enlargement and low platelets. Liver failure follows when the liver can no longer perform its core functions and may require transplant.

When years of bile-flow blockage and cell injury accumulate, the liver develops extensive fibrosis that we call cirrhosis. At this stage the liver becomes hard and shrunken, and several new problems can appear:

Portal hypertension

Blood that normally flows easily through the liver now meets resistance. Pressure builds in the portal vein and forces blood into smaller, fragile veins called varices, most often in the oesophagus and stomach. If these varices burst, the patient vomits blood, which is a life-threatening emergency. An upper gastrointestinal endoscopy is recommended at diagnosis of cirrhosis and periodically afterwards to look for varices and to band them if they are large.

Ascites and spontaneous bacterial peritonitis

Fluid collecting in the abdomen can become infected, a condition called spontaneous bacterial peritonitis (SBP). Symptoms include fever, abdominal pain and worsening confusion. SBP is treated with antibiotics and is a sign that the liver disease has become serious.

Hepatic encephalopathy

Toxins such as ammonia that the liver normally clears begin to reach the brain. Treatment is usually with lactulose (a syrup that increases bowel movements and removes ammonia) and sometimes with rifaximin, an antibiotic that lowers ammonia-producing gut bacteria. AtHomeCare nurses trained in liver care help families use lactulose correctly, because the dose is “titrated” โ€” adjusted until the patient has two to three soft stools a day.

Liver failure and transplant

When the liver can no longer sustain its work, the only effective treatment is a liver transplant. Patients are usually referred for transplant assessment when they develop their first major decompensation event (ascites, variceal bleeding, encephalopathy or jaundice), and a scoring system helps the team decide timing.

Treatment options for PSC

Answer: There is no cure for PSC and no drug has been proven to slow the disease in most patients. Treatment focuses on managing symptoms (itching, fatigue), treating complications (strictures, infections), surveillance for cancer, and liver transplant in advanced disease. Care is highly individualised by a hepatologist.

Treatment in PSC is best thought of as a long-term plan with several separate goals, each handled differently:

Treatment goals in PSC and how each is managed
GoalApproach
Slow the diseaseNo proven drug for most patients; clinical trials ongoing
Relieve itchingCholestyramine, rifampicin, naloxone, sertraline in stepwise fashion
Treat fatigueRule out other causes (anaemia, thyroid, sleep apnoea); gradual exercise
Manage stricturesERCP with balloon dilation, stenting or brushings
Treat infectionsAntibiotics for acute cholangitis; prophylaxis after recurrent episodes
Replace vitaminsOral fat-soluble vitamins A, D, E and K if deficient
Protect bonesCalcium, vitamin D, bone density scan, bisphosphonates if needed
Screen for cancerRegular ultrasound, MRCP, CA 19-9, colonoscopy in IBD
Treat end-stage diseaseLiver transplant assessment and listing

The most important principle is that treatment decisions are made by a hepatologist and individualised. What works for one patient may be inappropriate for another. Home nursing does not replace this specialist care; it supports it by ensuring the plan is followed safely between visits.

Medications used in PSC

Answer: Medications in PSC are mostly used for symptom relief and complication prevention, not to cure the disease. Common drugs include cholestyramine and rifampicin for itching, antibiotics for cholangitis, lactulose and rifaximin for encephalopathy, fat-soluble vitamins for deficiency, and ursodeoxycholic acid in selected low doses.

Several medicines appear regularly in PSC care. Understanding what each one does helps families feel more in control:

Ursodeoxycholic acid (UDCA)

UDCA is a bile acid that improves bile flow. It was once used in high doses hoping to slow PSC, but studies showed it did not improve survival and high doses may even be harmful. Low to moderate doses (13 to 15 mg per kilogram per day) are still sometimes used to improve liver enzymes and to help with itching, but always under hepatologist supervision.

Itching medicines

Itching in cholestasis is treated in a stepwise way. First-line is cholestyramine, a powder taken before and after breakfast. If that is not enough, rifampicin (an antibiotic that also helps itch) is added. Third-line options include opioid antagonists such as naltrexone, and the antidepressant sertraline. Each step is monitored for side effects.

Antibiotics

Acute cholangitis is treated with broad-spectrum intravenous antibiotics in hospital. Patients who have repeated episodes may be prescribed a low-dose oral antibiotic (such as ciprofloxacin) as prophylaxis, especially before ERCP.

Lactulose and rifaximin

These are used in hepatic encephalopathy. Lactulose dose is adjusted to produce two to three soft stools per day. Rifaximin is added when lactulose alone is not enough.

Fat-soluble vitamins and bone protection

Because bile flow is poor, absorption of vitamins A, D, E and K suffers. Blood levels are checked and oral supplements are given if low. Bone density is checked every two years, with calcium, vitamin D and bisphosphonates as needed.

Tip

Keep a single medicines list with the dose, timing and reason for each drug. Bring it to every appointment. AtHomeCare pharmacists and nurses help maintain this list and flag potential interactions with any new prescription.

ERCP for bile duct strictures

Answer: ERCP is an endoscopic procedure used to open narrowed bile ducts in PSC. A balloon stretches the stricture, a stent may be placed to keep the duct open, and brushings can be taken to check for cancer. It is done under sedation in hospital and usually requires a short stay.

When a “dominant stricture” causes jaundice, recurrent cholangitis or rising bilirubin, ERCP becomes a treatment tool rather than just a diagnostic one. The procedure works like this:

  1. Sedation: The patient is given sedation through a vein so they are comfortable and sleepy.
  2. Scope insertion: A flexible endoscope is passed through the mouth, down into the duodenum.
  3. Cannulation: A small catheter is passed into the ampulla of Vater, the point where the bile duct enters the intestine.
  4. Dye injection: Contrast dye is injected and X-ray images show the bile duct tree.
  5. Balloon dilation: A small balloon is inflated inside the narrowed segment to stretch it.
  6. Stent placement: A plastic or metal tube (stent) may be left in place to keep the duct open. Stents are changed periodically.
  7. Brushings: Cells are gently brushed from the stricture and sent to the lab to exclude cancer.

After ERCP, patients are observed for pancreatitis, bleeding and infection, the three main complications. Most people go home the same day or after an overnight stay. AtHomeCare nursing teams can support recovery at home by checking for fever, abdominal pain and jaundice over the following days.

Warning

If a person who has had a recent ERCP develops severe abdominal pain that radiates to the back, fever or vomiting, return to hospital immediately. These can be signs of pancreatitis or duct perforation, both of which need urgent treatment.

Liver transplantation in PSC

Answer: Liver transplant is the only treatment that can cure PSC in advanced disease. It is considered when the liver fails or when complications such as recurrent cholangitis or early bile duct cancer become life-threatening. Outcomes are generally good, but PSC can recur in the new liver in some patients over many years.

For most people with PSC, the disease progresses slowly, and many never need a transplant. For those who do, liver transplantation offers a real chance at a longer, healthier life. The decision is made by a transplant team using objective scores and clinical judgement.

When is transplant considered?

  • First major decompensation (ascites, variceal bleeding, encephalopathy).
  • Recurrent bacterial cholangitis that does not settle with treatment.
  • Intractable itching that ruins quality of life.
  • Early-stage cholangiocarcinoma meeting specific transplant criteria (the “Mayo protocol” in selected centres).
  • Progressive liver failure with falling albumin, rising bilirubin and prolonged INR.

Types of transplant

Two main types are used in India. In a deceased donor transplant, the whole liver comes from a brain-dead donor. In a living donor liver transplant, a portion of liver (usually the right lobe) is taken from a healthy related donor. Living donor transplant is more common in India because of organ availability, and the donor’s liver regenerates over weeks.

Life after transplant

Transplant patients need lifelong immunosuppression medicines to prevent rejection. These drugs need careful monitoring for side effects such as kidney strain, diabetes, high blood pressure and infection risk. AtHomeCare supports post-transplant patients at home with medication supervision, infection prevention, vital signs monitoring and coordination with the transplant team.

Tip

PSC can recur in the transplanted liver in roughly 10 to 20 percent of patients over many years. This is usually slow and manageable, but it means that monitoring continues even after a successful transplant. Also watch for inflammation of the colon, because ulcerative colitis can become more active after transplant.

Long-term monitoring plan for PSC patients

Answer: PSC monitoring combines regular blood tests (LFTs, CA 19-9, blood counts), imaging (ultrasound every six months, MRCP when needed), bone density scans, colonoscopy in patients with IBD, endoscopy for varices in cirrhosis and symptom tracking. A hepatologist sets the schedule, with home nursing support between visits.

Because no drug halts PSC, careful surveillance is the backbone of care. A typical schedule for a stable PSC patient is shown below; the exact intervals depend on disease stage and are decided by the hepatologist.

Suggested monitoring schedule for stable PSC (always tailor to the patient)
TestFrequencyPurpose
Liver function testsEvery 3 to 6 monthsTrack cholestasis and liver injury
Full blood count, INREvery 6 to 12 monthsDetect portal hypertension and clotting issues
CA 19-9Every 6 to 12 monthsBile duct cancer surveillance (non-specific)
Abdominal ultrasoundEvery 6 to 12 monthsGallbladder and bile duct cancer screening
MRCPWhen clinically indicatedInspect ducts for new strictures or masses
Colonoscopy (with IBD)Every 1 to 2 yearsColorectal cancer surveillance
Upper endoscopy (in cirrhosis)Every 1 to 3 yearsDetect and band oesophageal varices
Bone density scan (DEXA)Every 2 yearsDetect osteoporosis
Vitamin A, D, E, K levelsYearlyReplace if deficient
Liver stiffness (FibroScan)YearlyTrack fibrosis non-invasively
Home monitoring checklist
  • Record weight on the same scale, same time, twice a week.
  • Watch for new ankle or abdominal swelling and report rapid changes.
  • Check skin and eyes for yellowing weekly.
  • Note itching severity on a 0 to 10 scale.
  • Track stool colour; report pale, floating or greasy stools.
  • Keep a temperature log; report fever above 38ยฐC.
  • Keep all medicines, doses and next appointment dates in one file.
  • Bring the file and old reports to every clinic visit.

Diet, lifestyle and daily care in PSC

Answer: There is no special PSC diet, but a balanced, low-salt, liver-friendly diet with adequate protein, fat-soluble vitamin replacement and avoidance of alcohol is recommended. Staying active, managing weight, avoiding unnecessary drugs and supplements, and keeping up with vaccinations are all important for long-term wellbeing.

No diet cures PSC, but good nutrition helps the liver work as well as it can and lowers the risk of complications. Practical guidance for most PSC patients includes:

Everyday eating

  • Enough protein: eggs, fish, dal, paneer and curd help maintain muscle. In advanced disease with encephalopathy, protein intake is adjusted under medical guidance rather than cut drastically.
  • Low salt: less than 5 grams per day to reduce fluid retention when cirrhosis is present.
  • Regular meals: avoid long fasting periods; small, frequent meals suit patients with poor appetite.
  • Fat-soluble vitamins: take prescribed vitamins A, D, E and K as directed.
  • Coffee: some studies suggest two to three cups of unsweetened coffee a day may be associated with slower liver fibrosis, but check with the doctor before increasing caffeine.

Things to avoid

  • Alcohol: no level is safe in PSC; even small amounts add to liver injury.
  • Unnecessary supplements and herbal remedies: many “liver tonics” sold online can actually harm the liver. Always clear new products with the hepatologist.
  • Raw shellfish and unpasteurised dairy: these can carry infections that are more dangerous in chronic liver disease.
  • NSAIDs like ibuprofen: in cirrhosis they can harm the kidneys and raise bleeding risk. Use paracetamol in normal doses only as advised.

Lifestyle

  • Stay active: 30 minutes of walking most days helps muscle, mood and bone health.
  • Stop smoking: although smoking has a paradoxical protective effect on PSC risk, it harms the heart, lungs and cancer risk overall, so never smoke.
  • Vaccinations: hepatitis A and B, influenza, pneumococcal, COVID-19 and shingles vaccines are recommended in chronic liver disease.
  • Good sleep hygiene: especially important because sleep reversal can be an early sign of encephalopathy.

Living with PSC: emotional and practical aspects

Answer: Living with PSC means accepting a long, unpredictable illness while keeping a full life. Patients benefit from a clear care plan, honest conversations with the hepatologist, emotional support, advance planning for work and family, and a trusted home care partner who notices small changes early.

PSC is a marathon, not a sprint. Most people diagnosed today will live with the condition for decades, and quality of life depends as much on planning and emotional support as on medical treatment. Several practical steps help:

  • Understand the disease in your own words: ask the hepatologist to explain the current stage and what to expect over the next year.
  • Plan around unpredictability: keep emergency contact numbers visible at home and at work, and identify which Gurgaon hospital you will go to in an emergency.
  • Tell key people: a spouse, one trusted colleague and a close friend should know the diagnosis and the red-flag symptoms.
  • Maintain work and hobbies: staying engaged protects mental health. Fatigue is real, but pacing activities through the day helps.
  • Seek psychological support if needed: anxiety and depression are common in chronic illness and respond well to counselling.
  • Plan financially: health insurance, transplant coverage and an emergency fund reduce stress when complications arise.
Tip

Keep one notebook or a simple phone note for “today’s questions for the doctor.” Writing them down as they arise means nothing important is forgotten in the rush of a clinic visit.

AtHomeCare support for PSC patients in Gurgaon

Answer: AtHomeCare provides trained home nursing, patient attendants, medication and pharmacy support, equipment rental, physiotherapy and doctor coordination for PSC patients in Gurgaon. We work alongside the treating hepatologist, carry out the monitoring plan, watch for red flags and help families manage day-to-day care with confidence.

For families in Gurgaon caring for someone with PSC, the medical plan is set by the hepatologist, but most of the daily work happens at home. AtHomeCare bridges that gap with structured, clinically supervised support. Our services include:

Our teams do not replace your hepatologist. Instead, we extend the hepatologist’s plan into the home, document observations in a structured way, and escalate concerns early. This is especially valuable for working families in Gurgaon who cannot be physically present through the day but want to ensure that their loved one is monitored by trained clinical eyes.

AtHomeCare operational workflow: how we work

Answer: AtHomeCare follows a structured workflow that covers caregiver recruitment, background verification, training, clinical supervision, infection prevention, shift handovers, equipment logistics, pharmacy integration, home ICU deployment and emergency escalation. Each step is documented so that families know exactly who is caring for their loved one.

Trust in home healthcare comes from knowing how the care is delivered. We are transparent about our processes so families can make informed choices. The workflow below applies to every patient, including those with PSC.

Recruitment and screening

Nurses and attendants are recruited through a structured process that checks qualifications, prior experience and references. For nursing roles we verify the registration with the state nursing council. For attendant roles we look for prior home-care experience, basic life-support awareness and a calm, patient temperament suited to long illnesses.

Caregiver verification

Every caregiver undergoes identity verification (Aadhaar and address), police verification and a background check before being assigned. Their photo, full name and credentials are shared with the family in advance, so there are no surprises on the first day of care.

Training

Caregivers complete an induction covering basic nursing skills, infection prevention, patient dignity, fall prevention and emergency first response. Nurses receive additional training in chronic liver disease care, including recognition of encephalopathy, lactulose titration and stoma or drain management where relevant.

Supervision and quality monitoring

A clinical supervisor stays in regular touch with the family and the caregiver. Care notes are reviewed, and any deviation from the care plan is flagged. Quality is monitored through structured checklists, surprise visits and family feedback after each shift cycle.

Infection prevention

Hand hygiene, glove use, sterile technique for injections and dressings, and proper disposal of biomedical waste are non-negotiable. Caregivers are trained in current infection-control practices, which is critical for patients with cirrhosis who are vulnerable to infections.

Transportation coordination

For patients who need to travel to hospital for MRCP, ERCP or transplant clinic visits, our coordination team helps arrange suitable transport, including ambulance options when oxygen or stretcher support is required. We prepare a visit summary in advance so the hospital visit is efficient.

Accommodation support for long-term assignments

For long-duration live-in assignments, we help arrange suitable accommodation for the caregiver within the family home, with clear expectations on working hours, rest periods and shift coverage. This makes 24-hour care sustainable for both the patient and the caregiver.

Shift handovers

When care involves multiple shifts, each caregiver follows a written handover format covering vitals, medicines given, symptoms observed, intake-output and any concerns. The outgoing and incoming caregiver speak briefly, and a copy of the handover is shared with the family supervisor.

Integrated pharmacy

Our pharmacy team aligns with the prescription to deliver medicines on schedule, manage refills and flag expired stocks. For PSC patients on multiple drugs (UDCA, cholestyramine, lactulose, antibiotics), this avoids missed doses and dangerous interactions.

Equipment logistics

Beds, oxygen concentrators, suction units, monitors and IV stands are delivered, installed and serviced by our logistics team. Equipment is sanitised before deployment and serviced on a fixed schedule. Families receive a quick orientation on safe use.

Home ICU deployment

When a PSC patient needs ICU-level monitoring at home (for example, post-transplant or in advanced decompensation), a dedicated home ICU team is mobilised. This includes a critical-care nurse, a multipara monitor, oxygen support, infusion pumps and an escalation protocol to the nearest empanelled hospital.

Emergency escalation

Every care plan includes an emergency escalation pathway: who to call first, which hospital to go to, what documents to carry and how transport will be arranged. Caregivers are trained to recognise red flags (high fever, vomiting blood, severe drowsiness, sudden jaundice) and to act within minutes, not hours.

Decision tree: when to seek urgent care

Answer: PSC patients should seek urgent hospital care for high fever with chills, vomiting blood or black stools, sudden worsening jaundice, severe abdominal pain, marked drowsiness or confusion, and rapid abdominal swelling. Routine concerns like mild itching or stable weight can wait for the next clinic visit.

Symptom decision tree for PSC patients

Fever above 38ยฐC with chills and jaundice โ†’ Possible acute cholangitis. Go to hospital emergency the same day. Do not wait.
Vomiting blood or passing black, tarry stools โ†’ Possible bleeding varices. Call ambulance immediately; this is life-threatening.
Sudden drowsiness, confusion or slurred speech โ†’ Possible hepatic encephalopathy. Contact hepatologist or go to emergency the same day; lactulose may need urgent adjustment.
Sudden worsening jaundice with pale stools and dark urine โ†’ Possible new stricture or stone. Arrange MRCP and hepatology review within days.
Rapid increase in abdominal girth or ankle swelling โ†’ Possible worsening ascites. Contact hepatologist within 24 to 48 hours.
Persistent itching disturbing sleep โ†’ Book routine appointment to review itch medication; not an emergency.
Stable weight, stable LFTs, no new symptoms โ†’ Continue routine monitoring as per plan.

Disease and recovery timeline

Answer: PSC typically progresses over 10 to 20 years from silent early disease to cirrhosis, although the speed varies widely. After procedures like ERCP, recovery takes a few days. After liver transplant, the first three months are critical, with full recovery over six to twelve months under close immunosuppression monitoring.

Years 0 to 5: Silent phase

Often no symptoms. Detected through abnormal LFTs, usually during IBD monitoring. MRCP shows early beading. Focus: confirm diagnosis, set monitoring schedule, start cancer surveillance.

Years 5 to 10: Symptomatic phase

Fatigue and itching become more common. Occasional dominant strictures may need ERCP. Bone density and vitamin levels start needing attention. Focus: symptom control, ERCP when needed, lifestyle measures.

Years 10 to 15: Complication phase

Risk of cirrhosis, portal hypertension, recurrent cholangitis and cholangiocarcinoma rises. Variceal screening begins. Focus: tight cancer surveillance, manage decompensation events.

Years 15+: End-stage phase (for some)

Liver failure may develop. Transplant assessment is considered. Focus: transplant listing, supportive care, quality of life.

Post-ERCP recovery

Same-day discharge is common. Light diet for 24 hours. Watch for pancreatitis signs (severe abdominal pain, fever, vomiting) for 48 hours.

Post-transplant recovery

First 3 months: intensive monitoring, immunosuppression adjustment, infection prevention. 3 to 6 months: gradual return to normal activity. 6 to 12 months: stable phase with lifelong follow-up.

Frequently asked questions about PSC

Answer: These FAQs address the questions that patients and caregivers in Gurgaon most often ask about PSC, from diagnosis and symptoms to treatment, monitoring and daily care. Each answer is short, practical and aligned with current hepatology practice.
1. Is primary sclerosing cholangitis the same as primary biliary cholangitis?

No. Although the names sound similar, they are different diseases. PSC affects both small and large bile ducts and is strongly linked with inflammatory bowel disease, mostly in men. PBC mainly affects small ducts in middle-aged women and is associated with antimitochondrial antibodies. Diagnosis and treatment differ.

2. Can PSC be cured?

Currently there is no medical cure for PSC. Treatment focuses on relieving symptoms, treating complications such as strictures and infections, screening for cancer and, in advanced disease, performing a liver transplant. Many patients live well for years with careful monitoring.

3. How fast does PSC progress?

Progression is usually slow, often over 10 to 20 years, but it varies widely between individuals. Some people remain stable for decades, while others develop cirrhosis or complications more quickly. Regular monitoring helps detect changes early and tailor care.

4. What are the first symptoms of PSC?

Many people have no symptoms at first and PSC is found through abnormal liver function tests. When symptoms appear, they usually include fatigue, itching (especially at night), right upper abdominal discomfort and sometimes mild jaundice. Fever with chills suggests a bile duct infection.

5. Why is itching so common in PSC?

Itching happens because bile salts that should flow into the intestine instead build up in the blood and skin. This is called cholestatic pruritus. Treatments include cholestyramine, rifampicin, naltrexone and sertraline, used in a stepwise way under medical supervision.

6. Does everyone with PSC need a liver transplant?

No. Many people with PSC never need a transplant. Transplant is considered only when the liver fails or when complications such as recurrent cholangitis, intractable itching or early bile duct cancer become life-threatening. The decision is made by a transplant team using clinical scores.

7. What is the link between PSC and ulcerative colitis?

About 60 to 80 percent of people with PSC also have ulcerative colitis or, less commonly, Crohn’s disease. The two conditions share immune and gut-liver links. Patients with both need combined hepatology and gastroenterology care and a colonoscopy every one to two years because of higher colon cancer risk.

8. Is PSC hereditary?

PSC is not directly inherited in a simple pattern, but certain immune-related genes raise susceptibility. Having a first-degree relative with PSC slightly increases risk, although the absolute risk remains low. Most cases occur without a family history.

9. Can I drink alcohol if I have PSC?

No level of alcohol is considered safe in PSC. Even small amounts add to existing liver injury and can accelerate scarring. Patients with PSC are advised to avoid alcohol completely, including occasional social drinking.

10. What foods should I avoid with PSC?

Avoid alcohol, raw shellfish, unpasteurised dairy and high-salt foods if cirrhosis is present. Be cautious with herbal and “liver tonic” supplements, which can harm the liver. Always clear new supplements with your hepatologist. A balanced diet with adequate protein is generally recommended.

11. How often should I have liver function tests done?

For stable PSC, liver function tests are usually done every three to six months. More frequent testing may be needed after an ERCP, during a complication or when medicines are changed. Your hepatologist sets the exact interval based on disease stage.

12. What is a dominant stricture in PSC?

A dominant stricture is a significantly narrowed section of the common bile duct that can cause jaundice, cholangitis or rising bilirubin. It is usually treated with ERCP, where a balloon dilates the narrowed segment and a stent may be placed. Brushings are taken to exclude cancer.

13. Is PSC a cancer?

No, PSC itself is not cancer. It is a chronic inflammatory disease. However, PSC does raise the lifetime risk of bile duct cancer (cholangiocarcinoma), gallbladder cancer and, in patients with IBD, colorectal cancer. Regular screening is part of standard care.

14. Can PSC come back after a liver transplant?

Yes, PSC can recur in the transplanted liver in roughly 10 to 20 percent of patients over many years. Recurrence is usually slow and manageable. Even after transplant, ongoing monitoring is needed, and ulcerative colitis can become more active.

15. Should I take ursodeoxycholic acid (UDCA) for PSC?

UDCA is no longer recommended in high doses because studies showed it does not improve survival and may be harmful. Low to moderate doses may be used in selected patients to improve liver enzymes or itching, but only under hepatologist supervision. Never self-prescribe.

16. What is the risk of bile duct cancer in PSC?

The lifetime risk of cholangiocarcinoma in PSC is roughly 10 to 15 percent. There is no single reliable screening test, so surveillance combines regular ultrasound, MRCP when needed, CA 19-9 blood tests and ERCP with brushings for suspicious strictures.

17. How is fatigue in PSC managed?

Fatigue is common and hard to treat directly. The first step is to rule out other causes such as anaemia, thyroid disease, low vitamin D and sleep apnoea. Gradual exercise, good sleep hygiene, pacing activities through the day and treating any depression all help.

18. Can I work and travel with PSC?

Yes, most people with PSC continue to work and travel. Plan around clinic visits and medication schedules. Carry a brief medical summary, a list of medicines and emergency contacts. Avoid travel to areas with poor sanitation when cirrhosis is present, and check vaccination requirements well in advance.

19. How can home nursing help a PSC patient in Gurgaon?

Home nursing supports the hepatologist’s plan by tracking vitals, weight and symptoms, managing medicines such as lactulose, giving injections, recognising red flags and coordinating clinic visits. This is especially useful for working families or for patients with advanced disease who need closer monitoring between hospital visits.

20. When should a PSC patient go to hospital immediately?

Go to hospital immediately for high fever with chills, vomiting blood or black stools, sudden severe drowsiness or confusion, sudden worsening jaundice with pale stools, or severe abdominal pain. These suggest acute cholangitis, variceal bleeding, encephalopathy or a new stricture, all of which need urgent treatment.

Get specialist-supported home care for PSC in Gurgaon

Speak to our care advisors today. We will help you build a structured monitoring and nursing plan that works alongside your hepatologist’s advice.

Dr. Anil Kumar, medical reviewer at AtHomeCare

Dr. Anil Kumar

Medical Reviewer, AtHomeCare Clinical Team

This article has been clinically reviewed for medical accuracy, clarity and YMYL compliance. The content reflects current hepatology practice for primary sclerosing cholangitis and is intended to support, not replace, the advice of the treating hepatologist.

Doctor Name: Dr. Anil Kumar
Qualification: [Qualification โ€” to be supplied]
Speciality: [Speciality โ€” to be supplied]
Registration No.: RMC-79836
Years of Experience: 7

Doctor Review Summary

Reviewed by: Dr. Anil Kumar (Registration No. RMC-79836)

Review outcome: Approved for medical accuracy and patient clarity. The page covers PSC definition, bile duct pathophysiology, risk factors, symptoms, diagnosis (LFTs, MRCP, ERCP, biopsy), differential diagnosis, complications (cholangiocarcinoma, cirrhosis), treatment, transplant, long-term monitoring, diet and emergency red flags consistent with current hepatology guidelines.

Review date: 20 November 2026

Next scheduled review: 20 May 2027

This page is a health education resource and not a substitute for individual medical advice. Always consult your hepatologist for diagnosis and treatment decisions.